Substance / Medication

Tetrahydrozoline

Overview

Active Ingredient
tetrahydrozoline
RxNorm CUI
37935

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effect of fluorometholone/tetrahydrozoline fixed combination on conjunctival autograft morphology after primary pterygium excision.
Ozgurhan Engin Bilge, Kara Necip, Bozkurt Ercument et al. · Biomed Res Int · 2013
PMID: 23865053RCTFull text (PMC)
Use of tetrahydrozoline for chemical submission.
Stillwell Matthew E, Saady Joseph J · Forensic Sci Int · 2012
PMID: 22554870Case Report
Drug-facilitated sexual assault using tetrahydrozoline.
Spiller Henry A, Siewert Dennis J · J Forensic Sci · 2012
PMID: 22211761Case Report
Serum concentrations in three children with unintentional tetrahydrozoline overdose.
Lowry Jennifer A, Garg Uttam · Clin Toxicol (Phila) · 2011
PMID: 21740144Case Report
Naloxone use in a newborn with apnea due to tetrahydrozoline intoxication.
Katar Selahattin, Taskesen Mustafa, Okur Nilüfer · Pediatr Int · 2010
PMID: 20723124Case Report
Prolonged cardiovascular effects after unintentional ingestion of tetrahydrozoline.
Spiller Henry, Griffith Jill · Clin Toxicol (Phila) · 2008
PMID: 18259967Case Report
Patient use of Visine (tetrahydrozoline) masks Horner syndrome.
Lee M S, Harrison A R, Kardon R H · Br J Ophthalmol · 2008
PMID: 18156384Case Report
Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine).
Spiller Henry A, Rogers Jacqualine, Sawyer Tama S · Leg Med (Tokyo) · 2007
PMID: 17320456Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tetryzoline (substance)
SNOMED CT
372673004
UMLS CUI
C0076286
RxNorm CUI
37935

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.